It is a fact the pharmaceutical industry business model has been dramaticallyaltered. The industry no longer relies exclusively upon blockbusterdrugs to drive growth. There is an increasing relianceon small market drugs and a greater use of demographicallyfocused packaging in order to cater to thechild safe and senior friendly segments. The industryis in rapid transition from a supplydriven market to ademand and servicedriven market where manufacturingefficiency and responsiveness plays a criticalrole in future success.
